⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ELTX News
Elicio Therapeutics, Inc. Common Stock
ELTX INVESTOR ALERT: Holzer & Holzer, LLC Investigation of Elicio Therapeutics, Inc.
globenewswire.com
ELTX
Form 8-K
sec.gov
ELTX
Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer
globenewswire.com
ELTX
Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology
globenewswire.com
ELTX
Form 8-K
sec.gov
ELTX
Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
ELTX
Electra Therapeutics Announces First Patient Dosed in Phase 1 Study of Ipsoprubart (ELA026) in T Cell Malignancies
globenewswire.com
ELTX
Elicio Therapeutics to Present at the Bank of America Healthcare Conference
globenewswire.com
ELTX
Elicio Therapeutics Reports Inducement Grants
globenewswire.com
ELTX
Advancements in Novel Immunotherapeutics in The Oncology Battle Ready to Announce with Confidence?
newsfilecorp.com
AEMD
HURA
AZN
ELTX